MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Repros Therapeutics Company Profile (NASDAQ:RPRX)

Consensus Ratings for Repros Therapeutics (NASDAQ:RPRX) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $23.67 (1,179.28% upside)

Analysts' Ratings History for Repros Therapeutics (NASDAQ:RPRX)
Show:
DateFirmActionRatingPrice TargetActions
2/9/2016Piper JaffrayReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Brean CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Bank of AmericaDowngradeNeutral -> UnderperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2015LaidlawReiterated RatingBuy$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/29/2014Ascendiant Capital MarketsReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/31/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha